CPC
MACK

Cookson Peirce & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Cookson Peirce & Co’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,732
Closed -$214K – 157
2014
Q2 		$214K Buy
3,732
+924
+33% +$46.9K 0.05% 119
2014
Q1 		$111K Buy
+2,808
New +$120K 0.03% 136

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cookson Peirce & Co's MACK Position: Q3 2014 in Review

Cookson Peirce & Co sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2014, closing a stake of 3,732 shares — an estimated $214K sold.

Cookson Peirce & Co first reported a position in MACK in Q1 2014 and held it in 2 quarters. The position peaked at $214K in Q2 2014. 132 funds tracked by Wall St. Rank hold MACK as of Q3 2014.

  • Cookson Peirce & Co reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Cookson Peirce & Co sold 3,732 Merrimack Pharmaceuticals, Inc. shares in Q3 2014, an estimated $214K.
  • Cookson Peirce & Co first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Cookson Peirce & Co's Merrimack Pharmaceuticals, Inc. position peaked at $214K in Q2 2014.
  • 132 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2014.

Based on Cookson Peirce & Co's 13F filing for Q3 2014, filed 12 Nov 2014.